In this review, we will focus on the pathogenic role of the mTOR signaling in the development and progression of PAH and also discuss the possibility and potential to use specific inhibitors of mTOR signaling cascade to treat PAH. The gene discussed is MTOR; the disease is pulmonary arterial hypertension.